Reesink H - Search Results

1

HGV/GB virus C transmission by blood components in patients undergoing open-heart surgery.

Sentjens R, Basaras M, Simmonds P, Vrielink H, Reesink H. Sentjens R, et al. Among authors: reesink h. Transfusion. 2003 Nov;43(11):1558-62. doi: 10.1046/j.1537-2995.2003.00561.x. Transfusion. 2003. PMID: 14617315

2

HTLV-I/II prevalence in different geographic locations.

Vrielink H, Reesink HW. Vrielink H, et al. Among authors: reesink hw. Transfus Med Rev. 2004 Jan;18(1):46-57. doi: 10.1016/j.tmrv.2003.10.004. Transfus Med Rev. 2004. PMID: 14689377

3

Viral kinetics of hepatitis C virus RNA in patients with chronic hepatitis C treated with 18 MU of interferon alpha daily.

Sentjens RE, Weegink CJ, Beld MG, Cooreman MC, Reesink HW. Sentjens RE, et al. Eur J Gastroenterol Hepatol. 2002 Aug;14(8):833-40. doi: 10.1097/00042737-200208000-00004. Eur J Gastroenterol Hepatol. 2002. PMID: 12172402 Clinical Trial.

4

Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.

Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT. Koppelman MH, et al. Among authors: reesink hw. Transfusion. 2005 Aug;45(8):1258-66. doi: 10.1111/j.1537-2995.2005.00197.x. Transfusion. 2005. PMID: 16078910

5

Comparison of four HTLV-I and HTLV-I + II ELISAs.

Vrielink H, Reesink H, Habibuw M, Schuller M, van der Meer C, Lelie P. Vrielink H, et al. Among authors: reesink h. Vox Sang. 1999;76(3):187-91. doi: 10.1159/000031047. Vox Sang. 1999. PMID: 10341336

6

Risk factors in hepatitis C virus-infected blood donors.

van der Poel C, Cuypers H, Reesink H, Choo QL, Kuo G, Han J, Quan S, Polito A, Verstraten J, van de Wouw J, et al. van der Poel C, et al. Among authors: reesink h. Transfusion. 1991 Oct;31(8):777-9. doi: 10.1046/j.1537-2995.1991.31892023508.x. Transfusion. 1991. PMID: 1926325

7

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.

Jongerius JM, Sjerps M, Cuijpers HT, van Drimmelen HA, van der Poel CL, Reesink HW, Molijn MH, Peeters GA, Peeters TP, Lelie PN. Jongerius JM, et al. Among authors: reesink hw. Transfusion. 2002 Jun;42(6):792-7. doi: 10.1046/j.1537-2995.2002.00113.x. Transfusion. 2002. PMID: 12147034

8

Detection of bacteria in platelet concentrates: comparison of broad-range real-time 16S rDNA polymerase chain reaction and automated culturing.

Mohammadi T, Pietersz RN, Vandenbroucke-Grauls CM, Savelkoul PH, Reesink HW. Mohammadi T, et al. Among authors: reesink hw. Transfusion. 2005 May;45(5):731-6. doi: 10.1111/j.1537-2995.2005.04258.x. Transfusion. 2005. PMID: 15847662

9

Real-time amplification of HLA-DQA1 for counting residual white blood cells in filtered platelet concentrates.

Mohammadi T, Reesink HW, Vandenbroucke-Grauls CM, Savelkoul PH. Mohammadi T, et al. Among authors: reesink hw. Transfusion. 2004 Sep;44(9):1314-8. doi: 10.1111/j.0041-1132.2004.04114.x. Transfusion. 2004. PMID: 15318854

10

European strategies against the parasite transfusion risk.

Reesink HW. Reesink HW. Transfus Clin Biol. 2005 Feb;12(1):1-4. doi: 10.1016/j.tracli.2004.12.001. Transfus Clin Biol. 2005. PMID: 15814284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

456 results

Search Page